The Ahmedabad based leading Pharmaceutical company Zydus Cadila has obtained an approval from the US FDA to market benzepril tablets 5,10,20 and 40 mg. the drug falls in the cardiovascular segment and the combined sales of al the strengths as per NDC was estimated at US $301 million in 2007.
This marks the 38th AND approval for the group. So far, company has filled 78 ANDAs and 59 DMFs.
No comments:
Post a Comment